Mirion Technologies, Inc.

Greetings and welcome to the Merian Technologies for Square 2022 earnings conference call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press power zero on your telephone keypad. As a reminder, this conference is being recorded. It is my pleasure to introduce your host, Alex Getty. Thank you, Mr. Getty. You may begin.

Good morning, everyone, and thank you for joining Merion's fourth quarter and full year 2022 earnings call. A reminder that comments made during this presentation will include forward-looking statements, and actual results may differ materially from those projected in the forward-looking statements. The factors that could cause actual results to differ are discussed in our annual report, on Form 10-K and quarterly reports on Form 10-Q that we file from time to time with the SEC under the caption risk factors and in Miriam's other filings with the SEC. Quarterly references within today's discussion are related to the fourth quarter and full year ended December 31st, 2022. The comments made during this call will also include certain financial measures that were not prepared in accordance with generally accepted accounting principles. Reconciliation of those non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in the appendix of this presentation accompanying the call today. All earnings materials can be found on Merion's IR website at ir.merion.com. Joining me on the call today are Larry Kingsley, Chairman of the Board, Tom Logan, Chief Executive Officer, and Brian Schoffer, Chief Financial Officer. Now, I'll turn it over to our Chairman of the Board, Larry Kingsley. Larry?

Thank you, Alex, and good morning, everyone. I'd like to get today's call started by thanking you all for your continued support of Merion throughout our first full year as a public company. 22 was a dynamic year for Merion, from navigating a challenging supply chain environment to responding to record inflation and the Russia-Ukraine conflict. There was no shortage of hurdles to overcome. I'm incredibly proud, though, of the Myriad team's resolve in the face of adversity and believe the solid results we reported this morning are a direct testament. Our medical business accelerated upon recent growth trends, while industrial took a meaningful step forward during the quarter. Overall, the team was able to deliver on expectations laid out on our last call and has built positive momentum heading into 2023. Marion has positioned itself well to deliver growth this year, and I believe the guidance published this morning showcases the cycle-resistant nature of our strategic positioning in the market. Marion's diverse portfolio of products and services and experienced management team have a long track record of proven results. The team has the right roadmap in place to capitalize on what we expect will continue to be a robust demand environment. We are entering 23 with strong momentum across our end markets and a growing backlog. I'm also very encouraged by the execution-focused mentality we built through the course of 22. And the team has clear focus on the key strategic initiatives required for growth, profitability, and cash flow generation. The future for Merion is bright. Customer engagement and demand are strong. and our teams remain committed to executing. I'm now going to turn the call over to Tom Logan, Marion's CEO.